WINT

WINT

USD

Windtree Therapeutics Inc. Common Stock

$0.618-0.031 (-4.780%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$0.648

高値

$0.650

安値

$0.600

出来高

1.29M

企業ファンダメンタルズ

時価総額

2.3M

業種

バイオテクノロジー

United States

取引統計

平均出来高

4.53M

取引所

NCM

通貨

USD

52週レンジ

安値 $0.52現在値 $0.618高値 $737.5

関連ニュース

GlobeNewswire

Windtree Receives Offer for Its Preclinical Oncology Drug Candidate

Company to receive $7.0 million up front for its preclinical oncology drug candidate Up to $130.0 million in milestone payments starting with initiation of Phase 1 High single digit royalties that could total up to

もっと見る
Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
BusinessWire

Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors

Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the appointment of Saundra Pelletier, CEO of Evofem Biosciences, Inc.

もっと見る
Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors
GlobeNewswire

Windtree Announces Plan for Cryptocurrency Treasury Policy

WARRINGTON, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing

もっと見る
Windtree Announces Plan for Cryptocurrency Treasury Policy
GlobeNewswire

Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025

Istaroxime has previously completed two positive Phase 2 studies in SCAI Stage B cardiogenic shock; the SEISMiC C study in SCAI Stage C cardiogenic shock is another step progressing to the istaroxime cardiogenic shock

もっと見る
Windtree Therapeutics Announces Istaroxime Cardiogenic Shock SCAI Stage C Phase 2 Study Planned Interim Analysis Results Targeted for July 2025

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。